GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
TableEdit
PMID:15670776
You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki
See Help for Help on this wiki. See the documentation for how to use the table editor
Citation |
Lai, YP, Peng, YF, Zuo, Y, Li, J, Huang, J, Wang, LF and Wu, ZR (2005) Functional and structural characterization of recombinant dermcidin-1L, a human antimicrobial peptide. Biochem. Biophys. Res. Commun. 328:243-50 |
---|---|
Abstract |
Antimicrobial peptides from human skin are an important component of the innate immune response and play a key role as a first line of defense against infections. One such peptide is the recently discovered dermcidin-1L. To better understand its mechanism and to further investigate its antimicrobial spectrum, recombinant dermcidin-1L was expressed in Escherichia coli as a fusion protein and purified by affinity chromatography. The fusion protein was cleaved by factor Xa protease to produce recombinant dermcidin-1L. Antimicrobial and hemolytic assays demonstrated that dermcidin-1L displayed microbicidal activity against several opportunistic nosocomial pathogens, but no hemolytic activity against human erythrocytes even at concentrations up to 100 microM. Structural studies performed by circular dichroism spectroscopy indicated that the secondary structure of dermcidin-1L was very flexible, and both alpha-helix and beta-sheet structures might be required for the antimicrobial activity. Our results confirmed previous findings indicating that dermcidin-1L could have promising therapeutic potentials and shed new light on the structure-function relationship of dermcidin-1L. |
Links |
PubMed Online version:10.1016/j.bbrc.2004.12.143 |
Keywords |
Antimicrobial Cationic Peptides/chemistry; Antimicrobial Cationic Peptides/genetics; Antimicrobial Cationic Peptides/pharmacology; Bacteria/cytology; Bacteria/drug effects; Dose-Response Relationship, Drug; Escherichia coli/genetics; Escherichia coli/metabolism; Hemolysis/drug effects; Humans; Lethal Dose 50; Molecular Weight; Peptides/chemistry; Peptides/genetics; Peptides/pharmacology; Protein Conformation; Protein Structure, Secondary; Recombinant Proteins/chemistry; Recombinant Proteins/pharmacology; Structure-Activity Relationship |
public |
Cancel |